• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/104 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulfur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/104

Total number of patents in this class: 65

10-year publication summary

8
4
2
9
4
3
2
2
3
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Adverio Pharma GmbH
45
7
Akaal Pharma Pty Ltd.
11
4
Mitsui Chemicals, Inc.
3220
3
Convert Pharmaceuticals SA
5
3
Barry University, Inc.
4
2
Huizhou Huahong New Material Co., Ltd.
4
2
Interquim, S.A.
50
2
Korea University Research and Business Foundation
2987
2
Kyungpook National University Industry-Academic Cooperation Foundation
1142
2
Onyx Therapeutics, Inc.
68
2
Rappta Therapeutics Oy
9
2
Glaxo Group Limited
4065
1
Centre National de La Recherche Scientifique
10442
1
Asahi Glass Company, Limited
2781
1
Commissariat à l'énergie atomique et aux energies alternatives
10917
1
The Trustees of Columbia University in the City of New York
3577
1
The Board of Trustees of the University of Illinois
2695
1
Academia Sinica
940
1
Agfa-Gevaert
287
1
Araxes Pharma LLC
92
1
Other owners 25